GW Pharma Sales Grow 67% to $6.65 Million in December Quarter as Epidiolex Sales Commence

New Cannabis Ventures
By NCV NewswireFeb 26, 2019, 4:26 pm282 pts
GW Pharmaceuticals plc Reports Financial Results and Operational Progress for the Quarter Ended December 31, 2018 Epidiolex® (cannabidiol) oral solution (CV), first FDA-approved plant-derived cannabinoid medicine, launched in the U.S. in November to high awareness and demand GW moves to a new fiscal year-end…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Love, Legacy, and Legal Weed 79

Ohio tops $702 million in first year of adult-use cannabis sales 76

Q2 Cannabis Financial Updates Fail to Impress 70

Texas DA smokes weed on TikTok to fight THC ban 43

Another Federal Court Rules Dormant Commerce Clause Applies to Cannabis Licenses 43

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.